Effects of Pemafibrate on LDL-C and Related Lipid Markers in Patients with MASLD: A Sub-Analysis of the PEMA-FL Study.

Saved in:
Bibliographic Details
Title: Effects of Pemafibrate on LDL-C and Related Lipid Markers in Patients with MASLD: A Sub-Analysis of the PEMA-FL Study.
Authors: Tanigawa R; Global Clinical Development Department, Kowa Company Ltd.; Liver Center, Saga University Hospital., Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine., Eguchi Y; Loco Medical General Institute., Takahashi H; Liver Center, Saga University Hospital., Loomba R; MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego., Suganami H; Clinical Data Science Department, Kowa Company Ltd., Tanahashi M; Clinical Data Science Department, Kowa Company Ltd., Saito A; Global Clinical Development Department, Kowa Company Ltd., Iida Y; Global Clinical Development Department, Kowa Company Ltd., Yamashita S; Department of Cardiology, Rinku General Medical Center.
Source: Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2025 Jul 01; Vol. 32 (7), pp. 823-839. Date of Electronic Publication: 2024 Dec 18.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Japan Atherosclerosis Society Country of Publication: Japan NLM ID: 9506298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-3873 (Electronic) Linking ISSN: 13403478 NLM ISO Abbreviation: J Atheroscler Thromb Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1880-3873
DOI:10.5551/jat.65395